A large number of studies have shown that CD8 + T cells are associated with the benign prognosis of CRC [6–9], esophageal cancer [10], ovarian cancer [11], renal cell carcinoma [12], and pancreatic cancer [13]. The gene discussed is CD8A; the disease is colorectal carcinoma.